We are live on
!
Find out more
NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
1-Year Est. Return
8.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$33.3M
AUM Growth
-$1.73M
(-4.9%)
Cap. Flow
-$2.28M
Cap. Flow
% of AUM
-6.86%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
37
New
–
Increased
–
Reduced
31
Closed
1
Avg Time Held
11.8
quarters
Top 10 Avg Time Held
6.9
quarters
Top 20 Avg Time Held
9.3
quarters
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Markel Group
MKL
|
+$345K |
| 2 |
Aon
AON
|
+$257K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$236K |
| 4 |
Honeywell
HON
|
+$218K |
| 5 |
Microsoft
MSFT
|
+$205K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.93% |
| 2 | Financials | 20.68% |
| 3 | Technology | 13.98% |
| 4 | Consumer Staples | 12.35% |
| 5 | Industrials | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$333B
| $1.35M | 4.06% |
9,650
-1,050
| -10% | -$147K |
2013 Q2
13 quarters
|
|
|
2
Microsoft
MSFT
$3.88T
| $1.28M | 3.84% |
22,230
-3,625
| -14% | -$205K |
2015 Q3
4 quarters
|
|
|
3
Markel Group
MKL
$21.9B
| $1.28M | 3.84% |
1,375
-370
| -21% | -$345K |
2013 Q4
11 quarters
|
|
4
Intel
INTC
$566B
| $1.25M | 3.76% |
33,180
-1,600
| -5% | -$56.7K |
2013 Q2
13 quarters
|
|
|
5
Honeywell
HON
$65.5B
| $1.18M | 3.56% |
11,297
-2,087
| -16% | -$218K |
2013 Q2
13 quarters
|
|
6
Johnson & Johnson
JNJ
$618B
| $1.18M | 3.56% |
10,025
-1,440
| -13% | -$175K |
2013 Q2
13 quarters
|
|
7
Elevance Health
ELV
$87B
| $1.17M | 3.53% |
9,370
-10
| -0.1% | -$1.29K |
2013 Q2
13 quarters
|
|
8
Qualcomm
QCOM
$188B
| $1.16M | 3.48% |
16,925
-3,250
| -16% | -$198K |
2013 Q2
13 quarters
|
|
9
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.14M | 3.43% |
7,895
-410
| -5% | -$60K |
2013 Q2
13 quarters
|
|
10
Bank of America
BAC
$375B
| $1.14M | 3.42% |
72,706
-1,850
| -2% | -$27.5K |
2013 Q2
13 quarters
|
|
11
JPMorgan Chase
JPM
$881B
| $1.07M | 3.21% |
16,038
-1,550
| -9% | -$101K |
2013 Q2
13 quarters
|
|
12
Pfizer
PFE
$159B
| $1.04M | 3.13% |
32,426
-185
| -0.6% | -$6.19K |
2013 Q2
13 quarters
|
|
13
Yum! Brands
YUM
$39B
| $1.03M | 3.11% |
15,857
-1,127
| -7% | -$71.9K |
2013 Q2
13 quarters
|
|
14
Procter & Gamble
PG
$350B
| $1.02M | 3.07% |
11,390
-130
| -1% | -$11.3K |
2013 Q2
13 quarters
|
|
15
Kimberly-Clark
KMB
$32.5B
| $973K | 2.92% |
7,713
-10
| -0.1% | -$1.29K |
2013 Q2
13 quarters
|
|
|
16
Aon
AON
$58.8B
| $942K | 2.83% |
8,375
-2,335
| -22% | -$257K |
2013 Q2
13 quarters
|
|
17
Emerson Electric
EMR
$88.7B
| $941K | 2.83% |
17,265
-525
| -3% | -$28.1K |
2013 Q2
13 quarters
|
|
18
Chipotle Mexican Grill
CMG
$41.4B
| $910K | 2.73% |
107,400
-250
| -0.2% | -$2.06K |
2016 Q1
2 quarters
|
|
19
Chevron
CVX
$415B
| $869K | 2.61% |
8,445
-45
| -0.5% | -$4.59K |
2013 Q2
13 quarters
|
|
20
Fluor
FLR
$6.82B
| $861K | 2.59% |
16,785
-25
| -0.1% | -$1.29K |
2013 Q2
13 quarters
|
|
21
Merck
MRK
$351B
| $857K | 2.57% |
14,389
-26
| -0.2% | -$1.52K |
2013 Q3
12 quarters
|
|
22
Verizon
VZ
$193B
| $831K | 2.5% |
15,991
-116
| -0.7% | -$6.23K |
2013 Q2
13 quarters
|
|
23
Diageo
DEO
$48.4B
| $810K | 2.43% |
6,977
-35
| -0.5% | -$4K |
2013 Q2
13 quarters
|
|
24
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
| $801K | 2.41% |
17,400
-500
| -3% | -$26.1K |
2013 Q2
13 quarters
|
|
25
Bristol-Myers Squibb
BMY
$122B
| $800K | 2.4% |
14,830
| – | – |
2013 Q2
13 quarters
|
|
Similar funds
PRHC
BC
SCPM
SAM
BCP
AVA
GG
SM
Needelman Asset Management's Q3 2016 Portfolio in Review
As of Q3 2016, Needelman Asset Management held 37 positions worth $33.3M, down 4.9% from $35M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Needelman Asset Management withdrew a net $2.28M in Q3 2016, closing 1 position and reducing 31 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $236K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Financials and Technology.
- Needelman Asset Management's biggest Q3 2016 reduction was Markel Group, cutting an estimated $345K.
- Needelman Asset Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2016, selling an estimated $236K.
- Needelman Asset Management's ten largest holdings make up 36% of its $33.3M portfolio in Q3 2016.
- Needelman Asset Management opened 0 new positions and closed 1 in Q3 2016.
- Needelman Asset Management's portfolio value fell 4.9% quarter-over-quarter to $33.3M.
Based on Needelman Asset Management's 13F filing for Q3 2016, filed 13 Oct 2016.